Dr. Adil Khan is the Director of Point of Care Testing at Temple University and Episcopal Hospitals and Director of the Chemical Pathology Laboratories at Temple University and Episcopal Hospitals and Northeastern Ambulatory Care Center, Philadelphia, Pennsylvania, USA. He also holds an academic appointment at Temple University Lewis Katz School of Medicine as an Assistant Professor of Pathology. His research interests include understanding the role of adhesion molecules in leukocyte recruitment in health and disease; identifying novel markers of inflammation; clinical trials of point of care testing devices and clinical laboratory instruments.